A detailed medical memo released by the White House on March 9, 2026, has confirmed that President Donald Trump is managing a diagnosis of chronic venous insufficiency (CVI). The report, authored by the presidentâs primary physician, Dr. Sean Barbabella, characterizes the 79-year-old leaderâs health as excellent, emphasizing that the vascular condition does not suggest any underlying heart disease or deep vein thrombosis. The evaluation was prompted by mild swelling in the lower legs, a common symptom of CVI,
which occurs when weakened vein valves struggle to pump blood back to the heart against gravity. In a press briefing, White House Press Secretary Karoline Leavitt provided further clarity, noting that the diagnosis is typical for individuals in the presidentâs age bracket. She explained that CVI is widespread, potentially affecting up to 40% of Americans. The report also clarified that minor bruising on the presidentâs hands is a side effect of daily aspirin useâa standard preventive measure for cardiovascular healthâcompounded by the physical demands of frequent handshakes. Leavitt stressed that Trump remains fully capable of performing his duties, with no reported pain or loss of mobility. Treatment for the presidentâs condition involves non-invasive management techniques such as compression stockings and leg elevation during rest. This assessment builds upon his April 2025 physical, which similarly described his circulation as normal at the time. While the diagnosis has sparked discussion regarding leadership continuity and age, medical experts maintain that CVI is highly manageable through lifestyle adjustments and regular monitoring. The administration’s decision to release these findings reflects a commitment to transparency regarding presidential health. By addressing the symptoms directly, the White House aims to stifle speculation and reassure the public that President Trumpâs stamina remains intact for his official duties.
